Diagnosed With HoFH
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Phase II Clinical Trial to Evaluate the Efficacy and Safety of SYH2070 Injection in Participants With Homozygous Familial Hypercholesterolemia (NCT07591298) | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2026-05-24 |
Track Diagnosed With HoFH automatically
Every clearance here is in the API, with alerts when new ones post.